List of insiders holdings for TELA Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| EW HEALTHCARE PARTNERS FUND 2 L.P. EW HEALTHCARE PARTNERS FUND 2-A L.P. EW Healthcare Partners Fund 2 GP L.P. EW Healthcare Partners Fund 2-UGP LLC See Remarks 10% Owner | 2024-10-28 16:06:51 | 4,110,709 0 | 4,110,709 | Form 13G |
| Opaleye Management Inc. Former 10% Owner. | 2023-04-20 16:05:29 | 0 2,072,813 | 2,072,813 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 2024-10-25 16:24:30 | 1,182,717 0 | 1,182,717 | Form 13D |
| Ellis Ronald J. Jr. Pacira BioSciences Inc. Director 10% Owner | 2019-11-13 21:06:16 | 0 774,056 | 774,056 | Form 4 |
| Friedman Ashley Director | 2019-11-13 20:48:59 | 0 684,948 | 684,948 | Form 4 |
| Zuga Matt Director | 2019-11-13 20:57:28 | 0 623,924 | 623,924 | Form 4 |
| KOBLISH ANTONY Chief Executive Officer | 2024-10-24 16:25:31 | 458,897 0 | 458,897 | Form 4 |
| RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2023-02-14 10:10:15 | 390,364 0 | 390,364 | Form 13G |
| Cuca Roberto COO and CFO | 2024-10-24 16:26:40 | 155,388 0 | 155,388 | Form 4 |
| PERSENAIRE MAARTEN Chief Medical Officer | 2021-02-26 17:27:45 | 112,687 0 | 112,687 | Form 4 |
| Talmo Paul Chief Technology Officer | 2024-10-24 16:25:59 | 91,082 0 | 91,082 | Form 4 |
| Firestone Gregory A. Chief Commercial Officer | 2024-10-24 16:24:50 | 57,279 0 | 57,279 | Form 4 |
| Murphy Peter C. Chief Commercial Officer | 2024-04-02 19:42:50 | 48,129 0 | 48,129 | Form 4 |
| Smeykal Megan Chief Accounting Officer | 2024-04-02 19:43:54 | 29,000 0 | 29,000 | Form 4 |
| Greenhalgh Ellis Skott Chief Technology Officer | 2022-02-28 16:24:06 | 27,826 0 | 27,826 | Form 4 |
| Burgess Vincent J Director | 2024-06-06 17:00:09 | 21,580 0 | 21,580 | Form 4 |
| Quaker BioVentures II LP Quaker BioVentures Capital II L.P. 10% Owner | 2022-06-23 06:31:45 | 18,096 0 | 18,096 | Form 13G |
| Brennan Nora Chief Financial Officer | 2021-04-02 14:41:14 | 17,696 0 | 17,696 | Form 4 |
| O'Brien Federica F. Director | 2024-06-06 16:59:52 | 16,720 0 | 16,720 | Form 4 |
| COLLERAN LISA N Director | 2024-06-06 17:00:21 | 16,720 0 | 16,720 | Form 4 |
| Azarbarzin Kurt Director | 2024-06-06 17:00:31 | 16,720 0 | 16,720 | Form 4 |
| EVANS DOUGLAS G Director | 2024-06-06 17:00:47 | 16,720 0 | 16,720 | Form 4 |
| Blizard Jeffrey Director | 2024-06-06 16:55:53 | 15,675 0 | 15,675 | Form 4 |
| Nosenzo John Director | 2023-06-02 16:36:54 | 11,630 0 | 11,630 | Form 4 |
| Oliva Adele C Director | 2020-06-08 16:38:42 | 8,806 0 | 8,806 | Form 4 |